Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
181,793
-
Shares change
-
-2,802
-
Total reported value, excl. options
-
$150,424
-
Value change
-
-$16,235
-
Number of buys
-
4
-
Number of sells
-
5
-
Price
-
$0.8299
Institutional Holders of Predictive Oncology Inc. - COM (POAI) as of Q2 2025
As of 30 Jun 2025 Predictive Oncology Inc. - COM (POAI) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 181,793 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, STATE STREET CORP, CARNEGIE MELLON UNIVERSITY, RAYMOND JAMES FINANCIAL INC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/.
This table shows 11 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.